It’s the breakthrough we’ve all been waiting for. A dementia drug called lecanemab can effectively slow memory loss for people in the earliest stages of Alzheimer’s disease.
But there is more good news to share. Lecanemab opens a door for many further breakthrough treatments – with drugs that will be more powerful, have fewer side effects and which can benefit millions more people, living with every kind of dementia.
Today, we are asking for you to support our Drug Discovery Alliance, which brings together world-leading dementia scientists from across the UK.
in their sights is a brand-new drug, designed to fix faults in brain cells that cause dementia, which could lead to a new life-changing treatment.
This work builds on decades of dedicated scientific research. But to get it across the finish line, we need you.
More information here.